Delivery Order SPE2DE24D0013-SPE2D626F18VA
- Not listed
- Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems, was awarded a $7,480 firm fixed-price delivery order by the Defense Logistics Agency Medical Supply Chain on January 7, 2026, with an ultimate completion date of January 14, 2026. This delivery order, valued at the ceiling amount, is issued under Cepheid's larger Indefinite Delivery Contract with the Department of Veterans Affairs Veterans Integrated Service Network 17, which is valued at $6.7...
- The Defense Logistics Agency's Medical Supply Chain division awarded a $6,800 firm fixed-price delivery order to Cepheid Inc. on January 14, 2026, under contract number 4570533423 (XPRS4PLEX-10). This delivery order is a child contract issued under one of Cepheid's existing Indefinite Delivery Contracts with the Department of Veterans Affairs. The order calls for the delivery of XPRS4PLEX-10 cartridges and related molecular diagnostic testing reagents and assays designed for use with Cepheid's...
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a $34,000 firm fixed-price delivery order (Contract 4570371726, XPRS4PLEX-10) by the Defense Logistics Agency Medical Supply Chain on December 29, 2025, with an ultimate completion date of January 6, 2026. This delivery order, which carries no set-aside designation, is issued under Cepheid's existing Indefinite Delivery Contract with the Department of Veterans Affairs Veterans Integrated Service Network (VISN) 17, valued at...
- The Defense Logistics Agency Medical Supply Chain awarded a $2,040 firm fixed-price delivery order to Cepheid Inc. on January 20, 2026, with an ultimate completion date of January 27, 2026. This delivery order, designated XPRS4PLEX-10, represents a child contract under Cepheid's larger Indefinite Delivery Contract framework with the Department of Veterans Affairs Veterans Integrated Service Network (VISN) 17, valued at $6.74 million through December 28, 2029. The delivery order procures...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic systems, was awarded a $1,694 firm fixed-price delivery order (Contract No. XPRS-COV2-10) by the Defense Logistics Agency Medical Supply Chain on January 7, 2026. The delivery order, with an ultimate completion date of January 14, 2026, is issued under Cepheid's existing Indefinite Delivery Contract with the Veterans Health Administration VISN 17, valued at $6.7 million through December 28, 2029. The award carries...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems, was awarded a delivery order valued at $73,440 by the Defense Logistics Agency's Medical Supply Chain on January 16, 2026. This firm fixed-price delivery order, set to be completed by January 26, 2026, represents a child contract under a larger Indefinite Delivery Vehicle (IDV) with the Department of Veterans Affairs. The delivery order is expected to be performed at Cepheid's Sunnyvale location...
- The Defense Logistics Agency Medical Supply Chain awarded a $5,440 firm fixed-price delivery order to Cepheid Inc. on January 13, 2026, with an ultimate completion date of January 21, 2026. This delivery order, identified as XPRS4PLEX-10, is a child contract issued under Cepheid's existing Indefinite Delivery Contract with the Department of Veterans Affairs VISN 6, valued at $32.8 million and extending through September 30, 2030. The contract involves the supply of molecular diagnostic testing...
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a delivery order valued at $2,720.00 by the Defense Logistics Agency Medical Supply Chain on January 9, 2026, with an ultimate completion date of January 16, 2026. This firm fixed-price delivery order, designated XPRS4PLEX-10, represents a child contract with no set-aside designation and is issued under Cepheid's broader Indefinite Delivery Contract with the Department of Veterans Affairs Veterans Integrated Service Network (VISN)...
- The Defense Logistics Agency Medical Supply Chain awarded a $20,400 firm fixed-price delivery order to Cepheid Inc. on January 22, 2026, with completion targeted for January 29, 2026. This delivery order, designated XPRS4PLEX-10, represents a child contract under Cepheid's larger Indefinite Delivery Contract (IDC) with the Veterans Affairs VISN 6, valued at $32.8 million through September 30, 2030. The award carries no set-aside designation and will be performed at Cepheid's headquarters...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems, was awarded a $2,040 firm fixed-price delivery order (4570331464 | XPRS4PLEX-10) by the Defense Logistics Agency Medical Supply Chain on December 19, 2025, with an ultimate completion date of December 29, 2025. This delivery order, which carries no set-aside designation, is issued under Cepheid's larger Indefinite Delivery Contract with the Department of Veterans Affairs VISN 17, valued at $6.7...
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D626F18VADelivery Order
The Defense Logistics Agency Medical Supply Chain has awarded a delivery order valued at $14,552 to Cepheid Inc. under an Indefinite Delivery Contract with the Department of Veterans Affairs VISN 17. This firm fixed-price delivery order, issued on January 21, 2026, with an ultimate completion date of January 28, 2026, pertains to XPRS4PLEX-10 cartridges—molecular diagnostic reagents designed for Cepheid's GeneXpert diagnostic platform. The order represents a child contract without set-aside designation, performed at Cepheid's headquarters location in Sunnyvale, California. The rapid completion timeline reflects the urgent nature of diagnostic supply replenishment for federal healthcare operations. This award continues Cepheid's substantial role as a primary federal supplier of molecular diagnostic solutions across the Defense Health Agency and Veterans Affairs healthcare systems. Cepheid maintains significant indefinite delivery contracts with the VA, including a $6.7 million contract with VISN 17 specifically for GeneXpert diagnostic reagents and test kits extending through December 2029, under which this delivery order is issued. The company specializes in rapid molecular diagnostic testing for infectious diseases including COVID-19, influenza, respiratory syncytial virus, and tuberculosis, serving critical diagnostic needs across military medical centers and VA facilities nationwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $14.6k | 1/20/26 |